분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2018-02-01 23:59:10 , Hit : 614
 Severe Toxicity Reported in High-Dose AAV Gene Therapy in Animals

https://www.the-scientist.com/?articles.view/articleNo/51526/title/Severe-Toxicity-Reported-in-High-Dose-AAV-Gene-Therapy-in-Animals/&utm_campaign=TS_DAILY%20NEWSLETTER_2018&utm_source=hs_email&utm_medium=email&utm_content=60375850&_hsenc=p2ANqtz--UAWJsPDeDYrOcv2eGXij0pAM2ZqeXHlsHjnaNxFphh6BaagK9Gq46gjnyDPae5HESSi8FjAgfq0D4_rvPqstIAGh4yA&_hsmi=60375850/

The Scientist »
The Nutshell

Biotech stocks fell in response to the news.

By Jim Daley | January 31, 2018

Researchers reported severe, life-threatening toxicity in nonhuman primates and piglets treated with high-dose, adeno-associated virus (AAV9) gene therapy this Monday (January 29) in Human Gene Therapy. The news caused stocks of several leading biotech companies to tumble.

James Wilson, a molecular biologist at the University of Pennsylvania, and his colleagues found that an AAV9 variant (AAVhu68) used to deliver a human gene to spinal cord motor neurons in rhesus monkeys and piglets resulted in severe toxicity affecting the liver and motor neurons. Symptoms began appearing within five days of administering the gene therapy. One monkey and three piglets had to be euthanized.

“AAV still remains, from my experience over three decades, one of the safest delivery systems,” Wilson tells Xconomy. “We should expect with any biologic product that if you push the dose high enough, you’re going to encounter dose-limiting toxicities.”

Earlier this month, Wilson left his position on Solid Biosciences’s scientific advisory board, citing concerns about possible risks associated with of high doses of AAV vectors, which are used in the firm's muscular dystrophy gene therapy candidate, SGT-001. The Food and Drug Administration placed a partial clinical hold on SGT-001 last November, asking the company to make manufacturing adjustments and other changes before testing high doses of the drug.

In an accompanying editorial, Terence Flotte, the editor-in-chief of Human Gene Therapy, and Hildegard Büning, editor of Human Gene Therapy Methods, urge researchers to approach the study’s findings “in a balanced and responsible fashion.”

They note that the number of animals included in the study was small—only three per species—and that it was impossible to compare dose-response relationships with either liver or motor neuron toxicity because all animals were treated with the same dose. “[I]t is crucial that the members of our field neither ignore, nor overreact to these findings,” they write.

Stocks of three biotech companies—Avexis, Sarepta Therapeutics, and Solid Biosciences—fell when the study was announced.








1227   DNA Repair Mechanism Aids Cancer by Mending Chemo Damage  이성욱 2017/11/10 570
1226   Alcoholism Gene Therapy Shows Promise  이성욱 2017/09/20 583
1225   CRISPR Used in Human Embryos to Probe Gene Function  이성욱 2017/09/22 584
1224   [바이오토픽] CRISPR 기반 유전자치료를 방해하는 면역계  이성욱 2018/01/10 591
1223   암 면역요법, 일부 환자에게만 효과 있는 이유  이성욱 2018/01/12 591
1222   Nature Methods retracts CRISPR study  이성욱 2018/04/10 601
1221   From Startups to Moguls] CRISPR 유전자가위 없이 편집한다? Homology Medicines  이성욱 2017/09/11 607
1220   FDA Approves Gilead CAR-T Therapy Yescarta, Plans Regenerative Medicine Policy 'Soon'  이성욱 2017/10/20 610
  Severe Toxicity Reported in High-Dose AAV Gene Therapy in Animals  이성욱 2018/02/01 614
1218   CRISPR System Targets RNA in Mammalian Cells  이성욱 2017/10/06 641
1217   DNA Construction  이성욱 2017/09/15 661
1216   Advisors to FDA Recommend Approval of Gene Therapy for Blindness  이성욱 2017/10/14 666
1215   2018 Lasker Award Winners: Gene Expression Researchers, Propofol Discoverer, Pioneer for RNA Biology, and Women in STEM  이성욱 2018/09/12 671
1214   [바이오토픽] 체크포인트 저해제의 부작용: 자가면역질환 초래  이성욱 2017/11/16 689
1213   First CAR T-Cell Therapy Approved in U.S.  이성욱 2017/09/01 692
1212   UPDATED: FDA ushers in a new era in cancer treatment with ‘historic’ CAR-T approval for Novartis  이성욱 2017/08/31 696
1211   [바이오 업계 소식: From Startups to Moguls] CRISPR-Cas9에 대한 경고와 업계 반응  이성욱 2017/06/14 702
1210   Tunable Form of CRISPR Is an Efficient Regulator of Stem Cell Expression  이성욱 2016/03/14 703
1209   Mammalian Immunity: What’s RNAi Got to Do with It?  이성욱 2017/07/25 705
1208   코오롱 인보사허가  이성욱 2017/07/12 706

[1][2] 3 [4][5][6][7][8][9][10]..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN